- In February 2025, BD launched a next-generation pen needle with tactile grip and audible click feedback for safer home injections
- In September 2024, Novo Nordisk received CE Mark approval for an eco-friendly pen needle compatible with smart insulin pens in Europe
- In May 2024, Ypsomed introduced a short safety needle with extra-thin wall technology that enhances medication flow rate and reduces penetration force
- In March 2024, MTD Group acquired Ypsomed’s pen needle and blood glucose monitoring businesses, significantly expanding its market presence and product portfolio in diabetes care
- In July 2024, Embecta Corp. announced it was exploring a potential sale of the company due to reduced profitability and valuation drop, indicating consolidation trends and shifting business strategies in the insulin delivery market
